ribavirin has been researched along with tyrosine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boswell, HS; Burgess, GS; Collart, FR; Gharehbaghi, K; Huberman, E; Jayaram, HN; Litz-Jackson, S | 1 |
Sallee, NA; Shokat, KM; Ulrich, SM | 1 |
Guillén Schlippe, YV; Hedstrom, L; Riera, TV; Seyedsayamdost, MR | 1 |
Fuchs, D; Schloegl, A; Schroecksnadel, S; Vogel, W; Zoller, H | 1 |
4 other study(ies) available for ribavirin and tyrosine
Article | Year |
---|---|
p210 bcr-abl confers overexpression of inosine monophosphate dehydrogenase: an intrinsic pathway to drug resistance mediated by oncogene.
Topics: Animals; Antineoplastic Agents; Blotting, Northern; Cell Division; Cell Line, Transformed; DNA Replication; Drug Resistance; Fusion Proteins, bcr-abl; Gene Expression; IMP Dehydrogenase; Mice; Oncogenes; Phosphoproteins; Phosphotyrosine; Poly A; Ribavirin; RNA; RNA, Messenger; Thymidine; Tyrosine | 1994 |
Conformational restraint is a critical determinant of unnatural nucleotide recognition by protein kinases.
Topics: Adenosine Triphosphate; Humans; Hydrogen Bonding; Mitogen-Activated Protein Kinases; Molecular Conformation; Mutation; Nucleotides; p38 Mitogen-Activated Protein Kinases; Protein Kinases; Ribavirin; Structure-Activity Relationship; Substrate Specificity; Tyrosine | 2002 |
Substitution of the conserved Arg-Tyr dyad selectively disrupts the hydrolysis phase of the IMP dehydrogenase reaction.
Topics: Adenosine Diphosphate; Alanine; Amino Acid Substitution; Animals; Arginine; Binding Sites; Cattle; Conserved Sequence; Deuterium Exchange Measurement; Enzyme Inhibitors; Hydrolysis; IMP Dehydrogenase; Kinetics; Mutagenesis, Site-Directed; Mycophenolic Acid; Phenylalanine; Point Mutation; Protein Binding; Ribavirin; Ribonucleosides; Ribonucleotides; Solvents; Substrate Specificity; Tritrichomonas foetus; Tyrosine; Xanthine | 2004 |
Interferon-alpha therapy in patients with hepatitis C virus infection increases plasma phenylalanine and the phenylalanine to tyrosine ratio.
Topics: Adult; Biosynthetic Pathways; Chromatography, High Pressure Liquid; Female; Hepacivirus; Hepatitis, Chronic; Humans; Immunotherapy; Interferon-alpha; Male; Middle Aged; Mood Disorders; Phenylalanine; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Tyrosine; Viral Load | 2012 |